CCF Hematology Oncology Fellows
@ccfhemonc
Followers
670
Following
1K
Media
19
Statuses
883
Twitter account of the Hematology Oncology Fellows at Cleveland Clinic main campus
Cleveland, Ohio
Joined January 2023
🧵 1/7 Handgrip Strength (HGS) is emerging as an important metric in assessing muscle function and overall physical capability, especially in the aging population
pmc.ncbi.nlm.nih.gov
Hand grip strength (HGS) serves as a fundamental metric in assessing muscle function and overall physical capability and is particularly relevant to the ageing population. HGS holds an important...
1
2
8
Interesting differences in tumor microbiome in early-onset pancreatic cancer vs. average-onset PDAC. ⬆️ alpha diversity in eoPDAC. Greater alpha diversity ➡️ overall survival in eoPDAC. #ASCO24 #pcsm
https://t.co/qRDVWhkuu0
onclive.com
Suneel Kamath, MD, discusses the rationale for conducting an investigation into the tumor microbiome differences between early- and average-onset PDAC.
1
7
12
Thank you @jamecancerdoc for hosting breakfast for us. Appreciate your kindness, support, and mentorship!@LukasDelasos @MinhTriMD @Curley_MD @haikooshah @nerealiamd , missed you @DimaDanai , #TaylorBrooks @ccfhemonc
0
9
40
In Medicine: “sharp/dull/electric” help to narrow Dx. Same for emotions: to say “tired” when we mean “ennui” or perhaps “listless”. Wrong diagnosis ➡️wrong treatment. ⬆️ your emotional vocabulary. Know your audience. Know yourself. #vocab @CleClinicMD #leadership #communication
0
2
3
Beautiful #cleveland 😀
0
1
21
Thank you @JamesClearyMD for the opportunity to work on the review with you! #immunotherapy #analcancer
@BHuffmanMD @Rx_Devvrat @ccfhemonc @DanaFarber
@ThejusJay did a wonderful job with this review on immunotherapy in #analcancer. While a subset of patients have long-term responses to PD1i, most are resistant. New therapeutic approaches, and efforts to develop biomarkers, gives hope for the future. https://t.co/7ZTD6jdueO
3
3
11
Our graduating Gyn Onc fellow, @j_kelley3, presenting her thesis at the @caseccc Bench to Bedside Retreat. Thank you to @bikeVeloSano for supporting her dream experiment!
0
5
20
Extremely important! Nice article to read. We should give the distinction to Peter Salovey and John D. Mayer for coining/defining the term “Emotional Intelligence”. Daniel Goldman did a wonderful job introducing and popularizing #emotionalintelligence @CleveClinicFL @CleClinicMD
🧠❤️ Emotional intelligence can help you stay calm and collected under pressure, manage awkward moments with grace and relate to just about anyone you meet. ➡️Do you have it? https://t.co/n4EfKuUwdk
0
1
6
Impact of Tumor Burden on Survival for Patients with EGFR-Mutant NSCLC Treated with Osimertinib https://t.co/IS9RNhvZye via @clevelandclinic Summary of research presented at #ASCO24 by @CleClinicMD fellow ➡️ thoracic oncology attending Dr. @LukasDelasos! #CleClinicCancer
consultqd.clevelandclinic.org
The number of visceral tumors and metastatic disease sites impacts survival in patients with stage IV EGFR-mutant NSCLC.
0
3
11
Breast Cancer Brain Metastasis: A Comprehensive Review | @JCOOP_ASCO @ASCO @MDAndersonNews @OncoAlert
https://t.co/8j9qDUkgzv
2
66
155
Wonderful meeting everyone in person!
Inaugural dinner officially as Precision Medicine Academic Consortium (PMAC)! @nerealiamd @MarlaLipsycMD @AndrewDavisMD @dradityabardia @MCristofanill @LGerratana @caterina_gianni @Podanymd @ArielleMedford Katherine Clifon #ASCO24
0
1
10
Current Approaches and Novel New Agents in the Treatment of Chronic Lymphocytic Leukemia | @JCO_ASCO @JCOOP_ASCO @OncoAlert @SagarLonialMD
https://t.co/7KXmDVotGN
0
5
13
I was invited to give #GrandRounds at the #TaussigCancerInstitute today! Amazing experience and I was so blessed to have a roomful of @CCF_IMCHIEFS #IMRP members, faculty and alumni come to support me! Even my dad and wife attended virtually! Thank you @ChrisWeeMD for the invite
1
3
52
@Pahwa @CCF_IMCHIEFS @ChrisWeeMD @ayalamanMD @dbasali @JosephSipko @ianpersits @JohnGaskillDO @jamecancerdoc @NituKataria @HadilZureigat @Dabbagh_MD @HopkinsHospMed @OslerResidency @ANiranjanAzadi @SocietyHospMed Same title but based on my original Grand Rounds from the fall at @CleClinicKids and full of @CCF_IMCHIEFS #IMRP #value
0
2
9
Thank you, @CParkMD for your infectious optimism, collaborative spirit, & for being a truly generous sponsor for many of us junior investigators! You truly pay it forward by connecting, educating, & mentoring so many in the oncology world! Proud to be your friend!! #ASCO24
⭐️Mentor and Mentee Moment at #ASCO24 . Loved learning from Dr. Jame Abraham as his heme onc fellow. Now as a mentor I get to help one of the brightest young minds. #Mentorship #PayItForward
@jamecancerdoc @YLeyfman
@PGrivasMDPhD @shilpaonc @montypal @neerajaiims
3
6
28
Thank you 🙏 @oncologytube and Allen Wilbanks! It was amazing 🤩 meeting you! Thank you for interviewing me and for all the amazing work that you do! Stay tuned for the video!
@CloneTracker 🙏 [Video Soon] for your insights on Therapy-related myeloid neoplasm risk score (TMNRS) #ASCO24 @CleClinicMD @CleClinicNews @OncoAlert Abstract: https://t.co/RIciUlIKUK
0
2
11
Thank you, @ASCO team for a stellar & whirlwind #ASCO24! We’re especially grateful for the new @ASCOTECAG lounge this year - a resounding success for networking & career development guidance! @AnaVManana @NazliDizman @Latinamd @neerajaiims
We are very proud of this year's #TECLounge with all the new amenities and superb educational sessions. We had great time learning, having fun and connecting with friends. Thank you @ASCO , @asco staff and @FernandoDiazMD1 for the recognition and all the hard work. @ASCOTECAG
0
2
16
Congrats @shilpaonc @ClevelandClinic on presenting PRO data for EV+P, which is the new standard in bladder cancer.
2
12
39